-
Products
- Infanrix Hexa
- Trelegy▼ Ellipta
- Toctino
- Ambirix
- Amoxil
- Anoro▼
- Avamys
- Bactroban
- Beconase
- Benlysta▼
- Betnovate
- Boostrix IPV
- Cervarix
- Cutivate
- Daraprim
- Dermovate
- Ellipta inhaler
- Engerix B
- Eumovate
- Fendrix
- Flixonase
- Flixotide
- Flolan
- Fluarix Tetra▼
- Fortum
- Havrix Monodose and Havrix Junior Monodose
- Imigran/Imigran Subject
- Incruse▼Ellipta
- Infanrix-IPV+Hib
- Integrilin
- Lamictal
- Malarone
- Menitorix
- Naramig
- Pentostam
- Priorix
- ReQuip
- ReQuip XL
- Relenza
- Relvar▼
- Rotarix
- Seretide
- Serevent
- Seroxat
- Synflorix
- Timentin
- Twinrix
- Valtrex
- Varilrix
- Ventolin
- Wellvone
- Zantac
- Zinacef
- Zinnat
- Zovirax
- Zyban
- Combodart
- Strimvelis
- Duac
- Bexsero▼
- Menveo
- Rabipur
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Additional note for medicines / vaccines with a black triangle:
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.’
